Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7K0V

Crystal structure of bRaf in complex with inhibitor GNE-0749

Summary for 7K0V
Entry DOI10.2210/pdb7k0v/pdb
DescriptorNon-specific serine/threonine protein kinase, N-(3,3-dimethylbutyl)-N'-{2-fluoro-5-[(5-fluoro-3-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)amino]-4-methylphenyl}urea, CHLORIDE ION, ... (4 entities in total)
Functional Keywordskinase, inhibitor, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (Human)
Total number of polymer chains4
Total formula weight133175.35
Authors
Yin, J.,Eigenbrot, C.E.,Wang, W. (deposition date: 2020-09-06, release date: 2021-05-26, Last modification date: 2023-10-18)
Primary citationHuestis, M.P.,Dela Cruz, D.,DiPasquale, A.G.,Durk, M.R.,Eigenbrot, C.,Gibbons, P.,Gobbi, A.,Hunsaker, T.L.,La, H.,Leung, D.H.,Liu, W.,Malek, S.,Merchant, M.,Moffat, J.G.,Muli, C.S.,Orr, C.J.,Parr, B.T.,Shanahan, F.,Sneeringer, C.J.,Wang, W.,Yen, I.,Yin, J.,Siu, M.,Rudolph, J.
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3 H )-quinazolinone Aryl Urea pan-RAF Kinase Inhibitor.
J.Med.Chem., 64:3940-3955, 2021
Cited by
PubMed Abstract: Optimization of a series of aryl urea RAF inhibitors led to the identification of type II pan-RAF inhibitor GNE-0749 (), which features a fluoroquinazolinone hinge-binding motif. By minimizing reliance on common polar hinge contacts, this hinge binder allows for a greater contribution of RAF-specific residue interactions, resulting in exquisite kinase selectivity. Strategic substitution of fluorine at the C5 position efficiently masked the adjacent polar NH functionality and increased solubility by impeding a solid-state conformation associated with stronger crystal packing of the molecule. The resulting improvements in permeability and solubility enabled oral dosing of . In vivo evaluation of in combination with the MEK inhibitor cobimetinib demonstrated synergistic pathway inhibition and significant tumor growth inhibition in a KRAS mutant xenograft mouse model.
PubMed: 33780623
DOI: 10.1021/acs.jmedchem.0c02085
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.93 Å)
Structure validation

229183

PDB entries from 2024-12-18

PDB statisticsPDBj update infoContact PDBjnumon